What is the share price of Laxmi Dental Ltd (LAXMIDENTL) today?
The share price of LAXMIDENTL as on 19th June 2026 is ₹223.74. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.What is the return on Laxmi Dental Ltd (LAXMIDENTL) share?
The past returns of Laxmi Dental Ltd (LAXMIDENTL) share are- Past 1 week: 4.07%
- Past 1 month: 13.00%
- Past 3 months: 26.27%
- Past 6 months: -14.47%
- Past 1 year: -43.25%
- Past 3 years: N/A%
- Past 5 years: -59.36%
What are the peers or stocks similar to Laxmi Dental Ltd (LAXMIDENTL)?
The peers or stocks similar to Laxmi Dental Ltd (LAXMIDENTL) include:What is the market cap of Laxmi Dental Ltd (LAXMIDENTL) share?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Laxmi Dental Ltd (LAXMIDENTL) is ₹1229.72 Cr as of 19th June 2026.What is the 52 week high and low of Laxmi Dental Ltd (LAXMIDENTL) share?
The 52-week high of Laxmi Dental Ltd (LAXMIDENTL) is ₹509.95 and the 52-week low is ₹155.88.What is the PE and PB ratio of Laxmi Dental Ltd (LAXMIDENTL) stock?
The P/E (price-to-earnings) ratio of Laxmi Dental Ltd (LAXMIDENTL) is 42.45. The P/B (price-to-book) ratio is 5.89.Which sector does Laxmi Dental Ltd (LAXMIDENTL) belong to?
Laxmi Dental Ltd (LAXMIDENTL) belongs to the Health Care sector & Health Care Equipment & Supplies sub-sector.How to buy Laxmi Dental Ltd (LAXMIDENTL) shares?
You can directly buy Laxmi Dental Ltd (LAXMIDENTL) shares on Tickertape. Simply sign up, connect your demat account and place your order.
Laxmi Dental Ltd
LAXMIDENTL Share Price
NSELAXMIDENTL Stock Scorecard
Performance
LowHasn't fared well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
HighShowing good signs of profitability & efficiency
Entry point
GoodThe stock is underpriced and is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
LAXMIDENTL Performance & Key Metrics
LAXMIDENTL Performance & Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| 42.45 | 5.89 | — |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 41.31 | 6.17 | 0.56% |
from 3 analysts
Price Upside
Earnings Growth
Rev. Growth
LAXMIDENTL Company Profile
Laxmi Dental Ltd manufactures and supplies a comprehensive range of dental products including prosthetics, aligners, and dental consumables, catering to dental laboratories and clinics.
LAXMIDENTL Sentiment Analysis
LAXMIDENTL Sentiment Analysis
LAXMIDENTL Stock Summary · February 2026
Laxmi Dental Limited demonstrated resilience in Q3 FY26, reporting a revenue increase of 7.1% year-on-year despite external challenges such as US tariffs and competitive pressures. The recent reduction in tariffs is expected to enhance profitability and customer engagement, particularly in the U.S. market, while strategic initiatives in digital dentistry aim to drive growth and operational efficiency. Although the domestic lab business faced softness, management remains optimistic about a strong recovery in Q4, bolstered by innovative product launches and a focus on international expansion. The company is committed to overcoming regulatory hurdles and enhancing digital penetration, recognizing the significant potential for growth in the evolving dental landscape.
LAXMIDENTL Stock Growth Drivers
LAXMIDENTL Stock Growth Drivers
7Revenue Growth and Financial Performance
Laxmi Dental Limited reported a revenue of INR 66 crores in Q3 FY26, marking a
International Market Expansion
The company has experienced significant growth in its international business, particularly in the US market,
LAXMIDENTL Stock Challenges
LAXMIDENTL Stock Challenges
5Decline in Sales and Revenue
The company experienced a significant decline in sales during the current quarter, which was unexpected
Margin Compression
Laxmi Dental Limited reported a significant decline in EBITDA margins, with a quarter-on-quarter drop of
LAXMIDENTL Forecast
LAXMIDENTL Forecasts
Price
Revenue
Earnings
LAXMIDENTL Share Price Forecast
LAXMIDENTL Share Price Forecast
All values in ₹
All values in ₹
LAXMIDENTL Company Revenue Forecast
LAXMIDENTL Company Revenue Forecast
All values in ₹ cr.
All values in ₹ cr.
LAXMIDENTL Stock EPS (Earnings Per Share) Forecast
LAXMIDENTL Stock EPS (Earnings Per Share) Forecast
All values in ₹
All values in ₹
LAXMIDENTL
LAXMIDENTL
Income
Balance Sheet
Cash Flow
LAXMIDENTL Income Statement
LAXMIDENTL Income Statement
| Quarter | dec 2023 | mar 2024 | jun 2024 | sep 2024 | dec 2024 | mar 2025 | jun 2025 | sep 2025 | dec 2025 | mar 2026 | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 47.99 | 55.36 | 66.67 | 57.85 | 62.25 | 62.71 | 67.32 | 74.65 | 68.12 | 76.31 | ||||||||||
| Operating & Other expenses | 44.42 | 44.09 | 46.36 | 48.39 | 52.05 | 51.14 | 53.69 | 61.24 | 64.85 | 60.45 | ||||||||||
| EBITDA | 3.57 | 11.27 | 20.31 | 9.46 | 10.20 | 11.57 | 13.63 | 13.41 | 3.27 | 15.86 | ||||||||||
| Depreciation/Amortization | 3.25 | 3.26 | 3.37 | 3.40 | 3.95 | 4.30 | 3.58 | 3.75 | 4.17 | 4.38 | ||||||||||
| PBIT | 0.32 | 8.01 | 16.94 | 6.06 | 6.25 | 7.27 | 10.05 | 9.66 | -0.90 | 11.48 | ||||||||||
| Interest & Other Items | 1.33 | 1.40 | 1.42 | 1.18 | 1.54 | 1.26 | 0.46 | 0.24 | 0.32 | 0.35 | ||||||||||
| PBT | -1.01 | 6.61 | 15.52 | 4.88 | 4.71 | 6.01 | 9.59 | 9.42 | -1.22 | 11.13 | ||||||||||
| Taxes & Other Items | -3.29 | -0.91 | -1.28 | -1.01 | -0.09 | 1.73 | 1.21 | 0.88 | -3.20 | 1.06 | ||||||||||
| Net Income | 2.28 | 7.52 | 16.80 | 5.89 | 4.80 | 4.28 | 8.38 | 8.54 | 1.98 | 10.07 | ||||||||||
| EPS | 76.30 | 247.01 | 3.24 | 2.12 | 0.88 | 0.79 | 1.53 | 1.59 | 0.37 | 1.83 |
LAXMIDENTL Company Updates
Investor Presentation
LAXMIDENTL Stock Peers
LAXMIDENTL Past Performance & Peer Comparison
LAXMIDENTL Past Performance & Peer Comparison
Health CareHealth Care Equipment & Supplies
Valuation
Technical
Forecast
| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Laxmi Dental Ltd | 42.45 | 5.89 | — |
| Inventurus Knowledge Solutions Ltd | 38.92 | 15.69 | — |
| Poly Medicure Ltd | 49.19 | 5.73 | 0.22% |
| Tarsons Products Ltd | 97.58 | 2.22 | — |
LAXMIDENTL Stock Price Comparison
Compare LAXMIDENTL with any stock or ETFLAXMIDENTL Holdings
LAXMIDENTL Shareholdings
LAXMIDENTL Promoter Holdings Trend
LAXMIDENTL Promoter Holdings Trend
In last 6 months, promoter holding in the company has almost stayed constant
Pledged promoter holdings is insignificant
LAXMIDENTL Institutional Holdings Trend
LAXMIDENTL Institutional Holdings Trend
In last 3 months, retail holding in the company has increased by 1.34%
In last 3 months, foreign institutional holding of the company has decreased by 1.25%
LAXMIDENTL Shareholding Pattern
LAXMIDENTL Shareholding Pattern
LAXMIDENTL Shareholding History
LAXMIDENTL Shareholding History
Mutual Funds Invested in LAXMIDENTL
Mutual Funds Invested in LAXMIDENTL
No mutual funds holding trends are available
Top 5 Mutual Funds holding Laxmi Dental Ltd
| Funds (Top 5) | The rupee value of the stock held by the fund divided by the stock’s market cap Market-cap held | Percentage of the fund’s portfolio invested in the stock Weight | Change in the portfolio weight of the stock over the last 3 months 3M holding change | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months Portfolio rank(3M change) |
|---|---|---|---|---|
The rupee value of the stock held by the fund divided by the stock’s market cap 4.1885% | Percentage of the fund’s portfolio invested in the stock 0.80% | Change in the portfolio weight of the stock over the last 3 months 0.17% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 33/48 (+1) | |
The rupee value of the stock held by the fund divided by the stock’s market cap 1.2226% | Percentage of the fund’s portfolio invested in the stock 0.63% | Change in the portfolio weight of the stock over the last 3 months 0.02% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 33/37 (-6) | |
The rupee value of the stock held by the fund divided by the stock’s market cap 1.1357% | Percentage of the fund’s portfolio invested in the stock 1.14% | Change in the portfolio weight of the stock over the last 3 months 0.88% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 35/45 (+9) |
Compare 3-month MF holding change on Screener
smallcases containing LAXMIDENTL stock
smallcases containing LAXMIDENTL stock
Looks like this stock is not in any smallcase yet.
LAXMIDENTL Events
LAXMIDENTL Events
LAXMIDENTL Dividend Trend
LAXMIDENTL has not given any dividends in last 5 years
Dividends
Corp. Actions
Announcements
Legal Orders
LAXMIDENTL Dividend Trend
LAXMIDENTL has not given any dividends in last 5 years
LAXMIDENTL Dividends
LAXMIDENTL Dividends
LAXMIDENTL Stock News & Opinions
LAXMIDENTL Stock News & Opinions
The company's consolidated profit after tax after share of profit/loss from joint ventures surged 136.1% YoY to Rs 10.09 crore in Q4 FY26 from Rs 4.27 crore in Q4 FY25. Sequentially, PAT jumped 414.6% from Rs 1.96 crore reported in Q3 FY26. Revenue from operations rose 21.9% YoY and 12% QoQ to Rs 73.95 crore during the quarter. The company said Q4 FY26 marked its highest-ever quarterly revenue. EBITDA climbed 41.8% YoY and 93.8% sequentially to Rs 13.5 crore in Q4 FY26. EBITDA margin improved to 18.3% from 15.7% in the year-ago quarter and 10.5% in Q3 FY26. The company said EBITDA during the quarter was impacted by around 74 basis points due to higher US tariffs during the first half of the quarter. Gross profit margins stood at 70.5% during the quarter, showing sequential improvement despite a higher contribution from lower-margin scanner sales. The company said gross margins for the core dental business excluding scanner sales remained steady at around 76%. Profit before tax and exceptional items jumped 98.8% YoY to Rs 11.14 crore in Q4 FY26, while reported profit before tax rose 85.3% to Rs 11.14 crore from Rs 6.01 crore in Q4 FY25. On the cost front, raw material cost surged 187.35% YoY to Rs 11.81 crore in Q4 FY26. Employee benefit expenses rose 9.6% YoY to Rs 26.76 crore in Q4 FY26. Finance costs declined sharply by 72.2% to Rs 0.35 crore from Rs 1.26 crore, while depreciation and amortisation expenses increased marginally by 2.1% to Rs 4.38 crore from Rs 4.29 crore. Other expenses declined 14.2% YoY to Rs 11.87 crore from Rs 13.84 crore. For FY26, consolidated revenue from operations increased 16.2% YoY to Rs 277.86 crore from Rs 239.11 crore in FY25. EBITDA rose 3.6% to Rs 43.4 crore, while EBITDA margin stood at 15.6% compared with 17.5% in FY25. FY26 profit before tax and exceptional items rose 39.9% YoY to Rs 34.7 crore. However, reported profit before tax declined 9.1% to Rs 28.93 crore, while PAT after share of profit/loss from joint ventures fell 9.2% to Rs 28.92 crore. Management said FY26 margins were impacted by multiple one-off factors, including a 72 basis points impact from US tariffs, a one-time expense of Rs 5.78 crore related to labour code changes, and higher ESOP expenses of Rs 5.26 crore compared with Rs 2.19 crore in FY25. FY25 also included an exceptional gain of Rs 7.03 crore from property sale, making the base non-comparable. The company recorded a tax benefit of Rs 1.3 crore in Q4 FY26 related to the one-time gratuity provision recognised in Q3 FY26 following labour code changes. Net cash flow used in operating activities stood at Rs 4.99 crore in FY26 compared with net cash generated from operating activities of Rs 43.83 crore in FY25, mainly due to higher working capital deployment. Commenting on the performance, Rajesh Khakhar, chairperson and whole-time director of Laxmi Dental, said the company delivered its strongest-ever quarterly performance despite geopolitical uncertainties and higher US tariffs. He added that digital penetration in the Indian dental business stood at around 80%. Managing director and CEO Sameer Merchant said the dental laboratory business reported its highest-ever quarterly performance with 27% YoY growth, supported by recovery in domestic operations and record international revenue. The aligner solutions business reported revenue of Rs 18 crore during the quarter, while Bizdent, the clear aligner business, recorded 11% YoY growth. Laxmi Dental is an integrated dental products company engaged in manufacturing custom-made crowns and bridges, clear aligners, thermoforming sheets and other dental products with operations across India and exports to over 95 countries. Powered by Capital Market - Live
Net profit of Laxmi Dental rose 135.51% to Rs 10.08 crore in the quarter ended March 2026 as against Rs 4.28 crore during the previous quarter ended March 2025. Sales rose 19.46% to Rs 72.18 crore in the quarter ended March 2026 as against Rs 60.42 crore during the previous quarter ended March 2025. For the full year,net profit declined 8.78% to Rs 28.98 crore in the year ended March 2026 as against Rs 31.77 crore during the previous year ended March 2025. Sales rose 14.77% to Rs 271.50 crore in the year ended March 2026 as against Rs 236.56 crore during the previous year ended March 2025. ParticularsQuarter EndedYear EndedMar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var. Sales72.1860.42 19 271.50236.56 15 OPM %18.7015.77 -15.9917.70 - PBDT15.529.90 57 50.5839.82 27 PBT11.145.60 99 34.7124.80 40 NP10.084.28 136 28.9831.77 -9 Powered by Capital Market - Live
Laxmi Dental will hold a meeting of the Board of Directors of the Company on 21 May 2026.
However, total income jumped 9.43% to Rs 68.11 crore in Q3 FY26 as against Rs 62.24 crore in Q3 FY25. The company posted pre loss tax of Rs 1.28 crore in Q3 FY26 as against profit before tax of Rs 4.71 crore in Q3 FY25. EBITDA fell by 27.47% to Rs 6.97 crore in Q3 FY26, compared with Rs 9.61 crore recorded in the similar quarter last year. EBITDA Margin redcuced to 10.6% in Q3 FY26 as against 15.6% in Q3 FY25. Based on the requirements of the new labour codes, the company recorded an incremental impact of Rs 5.8 crore as an exceptional item for the quarter. Rajesh Khakhar, Chairperson and whole-time director (WTD) said, 'In Q3FY26, the company delivered revenues of Rs 660 Mn as against Rs 61.7 cr in same period last year, recording a YoY growth of 7%. The performance is despite global macroeconomic and geopolitical challenges, underscoring the strength and resilience of our diversified portfolio. Gross profit margins witnessed minor improvement sequentially due to steady profitability in the laboratory and aligner business alongside a relatively lower contribution of scanner sales, which are low margin in nature. Scanner sales hold strategic importance for future growth across segments. During Q3, we had a full quarter impact of 150 bps on account of higher US tariffs. Additionally, we recorded a one-time exceptional provision of Rs 58 Mn towards gratuity past service liability under the new labour code. With US tariff normalization, positive development of EU FTA, multiple ongoing strategic initiatives, and consolidation in the domestic dental market, Laxmi Dental is well positioned to deliver resilient, industry-leading growth along with improved profitability going ahead.' Sameer Merchant, Managing Director and CEO, said, 'For Q3FY26, our Dental Lab business recorded a healthy YoY growth of 10.4%, with the international business delivering robust 25.5% YoY growth, while the domestic lab remained soft. During the quarter, we implemented innovative strategies, which have started showing positive results in January 2026. Within the Aligner Solutions business, competitive pricing pressures on Bizdent are normalizing in Q4FY26, and we anticipate the situation to remain favorable throughout the quarter. With these new strategic initiatives, we are witnessing a strong recovery in our domestic Dental Lab and Bizdent businesses, and we expect both segments to deliver robust YoY performance in Q4FY26. On the back of these positive trends, we aim to close FY26 with a healthy exit quarter and begin FY27 on a stronger footing. Over the long term, we remain committed to promoting digital dentistry and leading this transformation across the Indian dental industry, leveraging our scanner solutions.' Laxmi Dental is an integrated dental products company offering a comprehensive portfolio of Dental Products. Powered by Capital Market - Live
Net profit of Laxmi Dental declined 58.75% to Rs 1.98 crore in the quarter ended December 2025 as against Rs 4.80 crore during the previous quarter ended December 2024. Sales rose 5.87% to Rs 64.02 crore in the quarter ended December 2025 as against Rs 60.47 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var. Sales64.0260.47 6 OPM %10.8715.89 - PBDT8.728.67 1 PBT4.554.71 -3 NP1.984.80 -59 Powered by Capital Market - Live
Laxmi Dental will hold a meeting of the Board of Directors of the Company on 10 February 2026.Powered by Capital Market - Live
Net profit of Laxmi Dental rose 44.82% to Rs 8.53 crore in the quarter ended September 2025 as against Rs 5.89 crore during the previous quarter ended September 2024. Sales rose 25.47% to Rs 70.98 crore in the quarter ended September 2025 as against Rs 56.57 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales70.9856.57 25 OPM %15.5315.41 - PBDT13.178.28 59 PBT9.424.88 93 NP8.535.89 45 Powered by Capital Market - Live
Laxmi Dental will hold a meeting of the Board of Directors of the Company on 11 November 2025.Powered by Capital Market - Live
Laxmi Dental announced that the Annual General Meeting(AGM) of the company will be held on 29 September 2025.Powered by Capital Market - Live
Laxmi Dental will hold a meeting of the Board of Directors of the Company on 12 August 2025.Powered by Capital Market - Live
Over the last 5 years, revenue has grown at a yearly rate of 10.2%, vs industry avg of 24.67%
Over the last 5 years, market share decreased from 6.19% to 2.93%